EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Recent advancements in Cancer Targeting Therapy with the Hyaluronic Acid as a Potential Adjuvant

Garima Gupta, Pulkit Asati, Pranjul Jain, Pranali Mishra, Ankit Mishra, Pradeep Singour

Ars Pharmaceutica (Internet) · 28.09.2022 · 63 (4) · 387-409

DOI: 10.30827/ars.v63i4.25208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ars Pharmaceutica (Internet), online erschienen am 28.09.2022. Verfasst von Garima Gupta und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The non-sulfated natural compound, Hyaluronic acid (HA), is a mucopolysaccharide that has an essential role in cellular biology; it is a fundamental element of the living cell. HA plays an essential role in targeted drug delivery; it has recently acquired much attention because of various advantages like biocompatibility, biodegradability, non-immunogenicity, and non-toxicity.

Methods

This narrative review is based on the literature searched with keywords Hyaluronic acid, Hyaluronic acid in cancer therapy, Hyaluronic acid in cancer targeting, Hyaluronic acid in drug targeting, was done on PubMed and Elsevier database from January to May 2021. Research published in the last five years was considered; however, no such timeline is followed in cross-referencing.

Results

From the literature, it is found that HA can recognize distinct receptors that are abnormally revealed in large numbers on the outer surface of cancerous tissues or cells; hence can be used for conjugation with anticancer drugs, facilitating their enhanced therapeutic activity over the cancer cells than normal cells. It is also found that HA-based systems also provide increased stability and solubility of anticancer agents in biological surroundings. Based on these findings and advantages, HA is conjugated with various delivery systems like micelles, liposomes, hydrogels, nanoparticles, etc. As per recent research, the HA-based system provides immunotherapy, gene therapy, targeted chemotherapy, and combination therapy with enormous applications in the evolution of highly efficacious and cost-effective therapy for the ministration of cancer.

Conclusion

In this context, various literatures on HA as adjuvant for drug delivery system for cancer targeting represents the HA as a potential adjuvant for cancer treatment.

Zitieren

APA

Gupta, G., Asati, P., Jain, P., Mishra, P., Mishra, A., & Singour, P. (2022). Recent advancements in Cancer Targeting Therapy with the Hyaluronic Acid as a Potential Adjuvant. Ars Pharmaceutica (Internet), 63(4), 387-409. https://doi.org/10.30827/ars.v63i4.25208

Vancouver

Gupta G, Asati P, Jain P, Mishra P, Mishra A, Singour P. Recent advancements in Cancer Targeting Therapy with the Hyaluronic Acid as a Potential Adjuvant. Ars Pharmaceutica (Internet). 2022;63(4):387-409. doi:10.30827/ars.v63i4.25208

BibTeX
@article{Gupta2022,
  author = {Gupta, Garima and Asati, Pulkit and Jain, Pranjul and Mishra, Pranali and Mishra, Ankit and Singour, Pradeep},
  title = {Recent advancements in Cancer Targeting Therapy with the Hyaluronic Acid as a Potential Adjuvant},
  journal = {Ars Pharmaceutica (Internet)},
  year = {2022},
  volume = {63},
  number = {4},
  pages = {387--409},
  doi = {10.30827/ars.v63i4.25208}
}
Kostenlos starten →